A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure

被引：2

作者：

Ong, Faustine ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Montalban-Bravo, Guillermo ^{[1
]}

Alvarado, Yesid ^{[1
]}

Ohanian, Maro ^{[1
]}

Konopleva, Marina ^{[2
]}

Jabbour, Elias ^{[1
]}

Jain, Nitin ^{[3
]}

Borthakur, Gautam ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Daver, Naval ^{[1
]}

Issa, Ghayas C. ^{[4
]}

Sasaki, Koji ^{[1
]}

Chien, Kelly S. ^{[1
]}

Takahashi, Koichi ^{[5
]}

Andreeff, Michael ^{[1
]}

Muftuoglu, Muharrem ^{[1
]}

Delumpa, Ricardo ^{[1
]}

Mayor, Ejiroghene ^{[1
]}

Loiselle, Christopher ^{[1
]}

Waller, Lourdes ^{[1
]}

Banks, Glenda ^{[1
]}

Kantarjian, Hagop ^{[6
]}

Cortes, Jorge E. ^{[7
]}

Short, Nicholas ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, CA USA

[2] Albert Einstein Coll Med, Bronx, NY USA

[3] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[4] Univ Texas Houston, Dept Leukemia, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX USA

[7] Georgia Canc Ctr, Augusta, GA USA

来源：

关键词：

D O I：

10.1182/blood-2022-165359

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6206 / 6208

页数：3